Core Insights - Accuray Incorporated announced the purchase of the CyberKnife® S7™ System by the Providence Swedish Radiosurgery Center, enhancing cancer treatment capabilities in Seattle, Washington [1][2] - The new system is designed for precision and speed, enabling faster delivery of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, thus improving patient access to effective treatment options [1][2] Company Overview - Accuray is focused on expanding the potential of radiation therapy to improve patient lives, offering innovative solutions for complex cases while simplifying treatment for more common cases [5] - The company emphasizes continuous innovation in radiation therapy for oncology and neuro-radiosurgery, partnering with clinicians to enhance patient care [5] Product Details - The CyberKnife S7 System is a non-invasive radiation therapy device that utilizes artificial intelligence to track and adapt to tumor or patient movement, delivering radiation with sub-millimeter precision in as little as 15 minutes [2][3] - The system represents a significant advancement in operational efficiency without compromising treatment accuracy, aligning with the goal of improving patient outcomes [2][3] Partnership and Impact - The partnership between Accuray and the Providence Swedish Radiosurgery Center has been ongoing for over a decade, with the center previously using the first CyberKnife System [2][3] - The center has contributed to the field of radiation medicine through significant clinical trials and ongoing research, demonstrating a commitment to advancing treatment methodologies [3]
Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions